NMDA receptor regulation of memory and behavior in humans

被引:145
作者
Newcomer, JW
Krystal, JH
机构
[1] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA
[2] Yale Univ, Sch Med, Dept Psychiat, New Haven, CT USA
关键词
NMDA; glutamate; memory; cognition; schizophrenia; psychosis;
D O I
10.1002/hipo.1069
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
N-methyl-D-aspartate (NMDA) receptor hypofunction is associated with a range of effects on cognition and behavior in whole animal and human studies. NMDA receptor hypofunction within the brain, which can be induced experimentally in vivo using NMDA receptor antagonist drugs, produces adverse effects on memory function. The results suggest that NMDA receptor hypofunction can preferentially affect neural mechanisms regulating the efficiency of encoding and consolidation into longer-term storage. More pronounced NMDA receptor hypofunction can produce a clinical syndrome that includes core features of psychosis, as well as dissociation. Finally, sustained and severe underexcitation of NMDA receptors in the adult brain is associated with a neurotoxic process with well-characterized neuropathological features. Progressive increases in severity of NMDA receptor hypofunction within the brain can produce a range of effects on brain function, involving local and distributed circuitry, which may underlie the observed changes in behavior. As the brain ages, the NMDA receptor system becomes progressively hypofunctional, potentially contributing to further age-related decreases in memory and learning performance. Pharmacological and genomic methods for preventing NMDA receptor hypofunction, or for preventing the upstream or downstream consequences modeled by treatment with NMDA antagonists, may be applicable to the prevention and treatment of memory and behavioral dysfunction in a variety of neuropsychiatric disease conditions. (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:529 / 542
页数:14
相关论文
共 188 条
[91]   Modulation of amphetamine-induced striatal dopamine release by ketamine in humans: Implications for schizophrenia [J].
Kegeles, LS ;
Abi-Dargham, A ;
Zea-Ponce, Y ;
Rodenhiser-Hill, J ;
Mann, JJ ;
Van Heertum, RL ;
Cooper, TB ;
Carlsson, A ;
Laruelle, M .
BIOLOGICAL PSYCHIATRY, 2000, 48 (07) :627-640
[92]   SELECTIVE IMPAIRMENT OF LONG-TERM BUT NOT SHORT-TERM CONDITIONAL FEAR BY THE N-METHYL-D-ASPARTATE ANTAGONIST APV [J].
KIM, JJ ;
FANSELOW, MS ;
DECOLA, JP ;
LANDEIRAFERNANDEZ, J .
BEHAVIORAL NEUROSCIENCE, 1992, 106 (04) :591-596
[93]   EFFECTS OF AMYGDALA, HIPPOCAMPUS, AND PERIAQUEDUCTAL GRAY LESIONS ON SHORT-TERM AND LONG-TERM CONTEXTUAL FEAR [J].
KIM, JJ ;
RISON, RA ;
FANSELOW, MS .
BEHAVIORAL NEUROSCIENCE, 1993, 107 (06) :1093-1098
[94]   REDUCTION OF CEREBROSPINAL-FLUID GLUTAMIC-ACID IN HUNTINGTONS-CHOREA AND IN SCHIZOPHRENIC-PATIENTS [J].
KIM, JS ;
KORNHUBER, HH ;
HOLZMULLER, B ;
SCHMIDBURGK, W ;
MERGNER, T ;
KRZEPINSKI, G .
ARCHIV FUR PSYCHIATRIE UND NERVENKRANKHEITEN, 1980, 228 (01) :7-10
[95]   LOW CEREBROSPINAL-FLUID GLUTAMATE IN SCHIZOPHRENIC-PATIENTS AND A NEW HYPOTHESIS ON SCHIZOPHRENIA [J].
KIM, JS ;
KORNHUBER, HH ;
SCHMIDBURGK, W ;
HOLZMULLER, B .
NEUROSCIENCE LETTERS, 1980, 20 (03) :379-382
[96]   Excessive cerebrocortical release of acetylcholine induced by NMDA antagonists is reduced by GABAergic and α2-adrenergic agonists [J].
Kim, SH ;
Price, MT ;
Olney, JW ;
Farber, NB .
MOLECULAR PSYCHIATRY, 1999, 4 (04) :344-352
[97]   THE NMDA-RECEPTOR ANTAGONIST CPP ABOLISHES NEUROGENIC WIND-UP PAIN AFTER INTRATHECAL ADMINISTRATION IN HUMANS [J].
KRISTENSEN, JD ;
SVENSSON, B ;
GORDH, T .
PAIN, 1992, 51 (02) :249-253
[98]   Interactive effects of subanesthetic ketamine and haloperidol in healthy humans [J].
Krystal, JH ;
D'Souza, DC ;
Karper, LP ;
Bennett, A ;
Abi-Dargham, A ;
Abi-Saab, D ;
Cassello, K ;
Bowers, MB ;
Vegso, S ;
Heninger, GR ;
Charney, DS .
PSYCHOPHARMACOLOGY, 1999, 145 (02) :193-204
[99]   SUBANESTHETIC EFFECTS OF THE NONCOMPETITIVE NMDA ANTAGONIST, KETAMINE, IN HUMANS - PSYCHOTOMIMETIC, PERCEPTUAL, COGNITIVE, AND NEUROENDOCRINE RESPONSES [J].
KRYSTAL, JH ;
KARPER, LP ;
SEIBYL, JP ;
FREEMAN, GK ;
DELANEY, R ;
BREMNER, JD ;
HENINGER, GR ;
BOWERS, MB ;
CHARNEY, DS .
ARCHIVES OF GENERAL PSYCHIATRY, 1994, 51 (03) :199-214
[100]   Interactive effects of subanesthetic ketamine and subhypnotic lorazepam in humans [J].
Krystal, JH ;
Karper, LP ;
Bennett, A ;
D'Souza, DC ;
Abi-Dargham, A ;
Morrissey, K ;
Abi-Saab, D ;
Bremner, JD ;
Bowers, MB ;
Suckow, RF ;
Stetson, P ;
Heninger, GR ;
Charney, DS .
PSYCHOPHARMACOLOGY, 1998, 135 (03) :213-229